Pamorelin LA 22.5 mg
Pamorelin LA 22.5 mg is a medicine authorised by Swissmedic under authorisation number 61238. The authorisation holder is Debiopharm Research & Manufacturing SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 09 March 2011 and the authorisation is valid without a time limit. ATC code L02AE04 places the medicine in the group Endocrine therapy.
| Authorisation number | 61238 |
|---|---|
| Name | Pamorelin LA 22.5 mg |
| Full name | Pamorelin LA 22.5 mg, poudre et solvant pour suspension injectable à libération prolongée |
| Authorisation holder | Debiopharm Research & Manufacturing SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L02AE04 |
| First authorisation | 09 March 2011 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Pamorelin LA 22.5 mg, poudre et solvant pour suspension injectable à libération prolongée | A | 09 March 2011 |
| 2 | Pamorelin LA 22.5 mg, poudre et solvant pour suspension injectable à libération prolongée | A | 07 September 2018 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Set | L02AE04 | 07.16.2. | A |
| 2 | 1 | Set | L02AE04 | 07.16.2. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Pamorelin LA 22.5 mg authorised in Switzerland?
Yes. Pamorelin LA 22.5 mg is authorised by Swissmedic under authorisation number 61238, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Pamorelin LA 22.5 mg have?
Pamorelin LA 22.5 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Pamorelin LA 22.5 mg?
The authorisation holder is Debiopharm Research & Manufacturing SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.